Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA staff question validity of benefit seen with AstraZeneca drug
FDA staff question validity of benefit seen with AstraZeneca drug
FDA staff question validity of benefit seen with AstraZeneca drug
Submitted by
admin
on June 23, 2014 - 9:42am
Source:
Yahoo/Reuters
News Tags:
FDA
AstraZeneca
olaparib
ovarian cancer
Headline:
FDA staff question validity of benefit seen with AstraZeneca drug
Do Not Allow Advertisers to Use My Personal information
